Private Equity Investor PLCPress Releases
About the Fund
Our Portfolio
Company Personnel
Annual Report
Interim Report
Regulatory News
General Meetings
Press Releases
Articles of Association
Share Price
Home
4th Floor, 23 Bentinck Street, London W1U 2EZ - Tel +44 (0)20 7563 1630 - Fax +44 (0)20 7486 4534
Net Asset Value 228.06p/341.20¢ inc. current period deficit; 228.73p/342.20¢ exc. current period deficit
per ordinary share at 30 June 2010 incorporating unaudited Revenue Reserves to 31 May 2010 (exchange rate, £1=US$1.4961).
For Limited Partnerships Revaluations see Our Portfolio.
Registered office
Beaufort House
51 New North Road
Exeter, EX4 4EP
Company Number
3912487 – England & Wales


HACKER SAFE certified sites prevent over 99.9% of hacker crime.
Connector
Opening the doors to world class opportunity at the venture stage
Linking IT investment in the UK and USA

1 DECEMBER 2000

Initial Public Offerings and trade sale of portfolio companies

The directors of Net Investor PLC are pleased to report that two further investments in its portfolio are now publicly traded companies. A trade sale has also taken place.

  • Adolor Corporation (ADLR) was listed on Nasdaq on 14 November 2000. Net Investor's participation is through the Sprout IX Limited Partnership. The listing price was $15 per share and the acquisition price was $5 per share.
  • Alliance Fiber Optic Products Inc. (AFOP) was listed on NASDAQ on 20 November 2000. Net Investor's participation is through New Enterprise Associates 9 Limited Partnership. The Listing price was $11 per share and the acquistion price was $5.50 per share.
  • E*Offering, also held within the New Enterprise Associates 9 Limited Partnership, was the subject of a trade sale. NEA 9's position, sold to Wit SoundView, was acquired at a cost of $5 mil. and had a sale value of $17mil.

In addition to the trade sale a total of nine portfolio companies have now made Initial Public Offerings since Net Investor launched in February this year.

Tim Childs, Managing Director of Net Investor, comments: "Given the volatile public market, we see these IPOs and the trade sale as an indication of the quality of the funds in which we have invested."


Enquiries
Tim Childs, Net Investor, Tel: 020 7930 5600
Fiona Monro, Grandfield, Tel: 020 7417 4170
Jeremy King, English Trust, Tel: 020 7608 0888


Notes to editors
The Company seeks to achieve substantial capital appreciation by investing in emerging growth companies through specialised US venture capital funds focused on the information technology, biotechnology and healthcare sectors.


Return to Press Release Index